CELL & GENE: An Analysis Of The Gene Therapy Viral Vector Landscape Back Bay Life Science AdvisorsApril 22, 2021
Creating the Optimal Term Sheet Investment Banking TeamApril 21, 2021Investment Banking, Term Sheets, IPOs
Mentoring Promising Life Science Companies from Japan’s Kansai Region Back Bay Life Science AdvisorsApril 16, 2021
Medtech Investors Take Note Investment Banking UpdateBack Bay Life Science AdvisorsMarch 8, 2021MedTech, HealthTech, Investing, Development, Investment Banking
Investment Banking Spotlight: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals Back Bay Deal TeamInvestment Banking TeamFebruary 23, 2021Biotech, M&A, Drug Development, Cannabidiol, Blockbuster, Life Sciences
The BioInnovation Institute Announces Partnership with Back Bay Life Science Advisors BlogBack Bay Life Science AdvisorsJanuary 28, 2021Emerging BioPharma, Denmark, Cross-border
PHARMACEUTICAL ONLINE: First In Line - FDA Vs. EMA Biopharma Approval Times Back Bay Life Science AdvisorsJanuary 20, 2021
MinervaX Announces Completion of 47.4 mEUR Financing [Back Bay Transaction] Investment Banking TeamJanuary 5, 2021
Analysis Of The Non-Alcoholic Steatohepatitis Drug Pipeline & Market Blog, White PaperBack Bay Life Science AdvisorsDecember 15, 2020NASH, Drug Development, Clinical Stage
Back Bay Life Science Advisors Announces Team Expansion and Promotions Back Bay Life Science AdvisorsDecember 14, 2020
ASH 2020 Preview Blog, EventsBack Bay Life Science AdvisorsNovember 30, 2020Cell Therapy, Oncology, hematology
ISD Immunotech, a Novo Seeds Portfolio Company, Enters Strategic Research Collaboration for the Development of a Novel Lupus Treatment [Back Bay Transaction] BlogInvestment Banking TeamNovember 23, 2020Biogen, Lupus, Novo, Transactions
Lobsor Pharmaceuticals AB is acquired by STADA Arzneimittel AG [Back Bay Transaction] Back Bay NewsBack Bay Life Science AdvisorsOctober 6, 2020Transactions, Financial Advising, Investment Banking
2020 IPO Class Performance Investment Banking Update, BlogBack Bay Life Science AdvisorsSeptember 23, 2020Biotech Financing, IPOs, Biotech, Investment Banking
CELL & GENE: Immunotherapy For Glioblastoma: A Path Forward Media Coverage, Back Bay in the NewsBack Bay Life Science AdvisorsAugust 11, 2020Gene Therapy, IO
Saving Antibiotic Drug Development Back Bay in the NewsBack Bay Life Science AdvisorsJune 29, 2020Anti-Infectives, Anti-Microbials, Drug Development
CELL & GENE: Looking Beyond Alpha-Beta Cells for Cell Therapies Back Bay in the NewsBack Bay Life Science AdvisorsMarch 27, 2020Gene Therapy
Back Bay Life Science Advisors Serves as Strategic and Financial Advisor to Codexis [Back Bay Transaction] Investment Banking UpdateInvestment Banking TeamMarch 23, 2020Transactions
STAT NEWS: Why Medtech is a Different Beast Than Biotech in the Life Sciences Pack Insights, Jonathan GertlerJonathan Gertler, MDFebruary 13, 2020Biotech, Medtech, diagnostics
